These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5687082)

  • 1. Pseudocholinesterase in obese and hyperlipemic subjects.
    Cucuianu M; Popescu TA; Haragus S
    Clin Chim Acta; 1968 Oct; 22(2):151-5. PubMed ID: 5687082
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia.
    Cucuianu M; Popescu TA; Opincaru A; Hărăgus S
    Clin Chim Acta; 1975 Feb; 59(1):19-27. PubMed ID: 164306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudocholinesterase and lipoprotein lipase in atherosclerosis.
    Hărăguş S; Cucuianu M; Popescu TA
    Cor Vasa; 1972; 14(1):33-41. PubMed ID: 5022129
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.
    Chu MI; Fontaine P; Kutty KM; Murphy D; Redheendran R
    Clin Chim Acta; 1978 Apr; 85(1):55-9. PubMed ID: 206388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature.
    Persson B
    Acta Med Scand; 1973 May; 193(5):457-62. PubMed ID: 4352145
    [No Abstract]   [Full Text] [Related]  

  • 6. Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia.
    Cucuianu M; Opincaru A; Tapalagă D
    Clin Chim Acta; 1978 Apr; 85(1):73-9. PubMed ID: 647966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum gamma-glutamyltransferase in hypertriglyceridemia: comparison with serum pseudocholinesterase.
    Cucuianu M; Zdrenghea D; Pop M; Opincaru A
    Clin Chim Acta; 1976 Sep; 71(3):419-27. PubMed ID: 9218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of hyperlipoproteinemia in diabetes mellitus].
    Gligore V; Hincu N; Tecuceanu R; Sopon E; Hoinărescu E; Cristea A
    Med Interna (Bucur); 1973 Oct; 25(10):1259-72. PubMed ID: 4792521
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen activator inhibitor in plasma and arteriosclerosis.
    Matsuda T; Morishita E; Jokaji H; Saito M; Kumabashiri I; Akakura H; Uotani C; Yamazaki M
    Ann N Y Acad Sci; 1995 Jan; 748():394-8. PubMed ID: 7695181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of serum pseudocholinesterase activity in diabetes mellitus].
    Gligore V; Hincu N; Scurtu-Marcu A; Tecuceanu R
    Med Interna (Bucur); 1972 Oct; 24(10):1243-51. PubMed ID: 4650754
    [No Abstract]   [Full Text] [Related]  

  • 11. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
    Wallentin L; Angelin B; Einarsson K; Leijd B
    Scand J Clin Lab Invest Suppl; 1978; 150():103-10. PubMed ID: 218268
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertriglyceridemia in weanling rats with hypothalamic obesity.
    Schnatz JD; Bernardis LL; Frohman LA; Goldman JK
    Diabetes; 1971 Oct; 20(10):655-63. PubMed ID: 5110697
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiologic studies of dyslipidemia in newly detected diabetes mellitus.
    Mincu I; Câmpeanu S; Dumitrescu C; Mihalache N; Bruckner I
    Rev Roum Med Intern; 1972; 9(6):537-50. PubMed ID: 4657673
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum pseudocholinesterase activity during experimental fattening.
    Popescu TA; Fekete T; Popescu E; Böjthy I; Laszlo M
    Med Interne; 1976; 14(1):71-3. PubMed ID: 946698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled application of cynarin in the treatment of hyperlipemic syndrome. Observations in 60 cases].
    Montini M; Levoni P; Ongaro A; Pagani G
    Arzneimittelforschung; 1975 Aug; 25(8):1311-4. PubMed ID: 170949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrylcholinesterase activity and risk factors for coronary artery disease.
    Alcântara VM; Chautard-Freire-Maia EA; Scartezini M; Cerci MS; Braun-Prado K; Picheth G
    Scand J Clin Lab Invest; 2002; 62(5):399-404. PubMed ID: 12387587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of cholinesterase activity in lipid metabolism disorders].
    Reuter W; Geus P
    Z Gesamte Inn Med; 1987 Jul; 42(13):371. PubMed ID: 3630286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholinesterase (CE) activity and lipid levels in hyperlipidemic rats.
    Wasan KM; Meltzer A; Luke DR
    Prog Clin Biol Res; 1990; 341A():193-8. PubMed ID: 2217234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Densitometric analysis of plasma lipoproteins on cellulose polyacetate. Study of 1783 lipoprotidograms from hyperlipemic subjects. II].
    Giacchi M; Lungarella G; Bertelli E
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1398-402. PubMed ID: 204319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of dimethylbiguanide (metformin) on peripheral insulin clearance and lipid biosynthesis in obese dyslipidemic subjects with and without diabetes mellitus].
    Caporicci D; Mori A; Pepi R; Lapi E
    Clin Ter; 1979 Feb; 88(4):372-86. PubMed ID: 455913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.